Antenatal diagnosis and treatment of congenital adrenal hyperplasia

Maria I. New

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Congenital adrenal hyperplasia (CAH) is a family of monogenic autosomal recessive disorders of steroidogenesis in which enzymatic defects result in impaired synthesis of cortisol by the adrenal cortex. The adrenal 21-hydroxylase (21-OH) enzyme is one of five enzymes necessary for the synthesis of cortisol from cholesterol, and its deficiency is the most common enzymatic defect causing CAH. 21-OH deficiency (21-OHD) occurs in a classical form that can cause genital ambiguity at birth in genetic females. Newborn males have normal genitalia. Prenatal treatment of 21-hydroxylase deficiency with dexamethasone has been used for approximately 15 years. An algorithm was developed for prenatal diagnosis and treatment.

Original languageEnglish
Pages (from-to)11-18
Number of pages8
JournalCurrent Urology Reports
Volume2
Issue number1
DOIs
StatePublished - Feb 2001
Externally publishedYes

Keywords

  • CYP11B1 Gene
  • Congenital Adrenal Hyperplasia
  • Human Lymphocyte Antigen
  • Prenatal Diagnosis
  • Prenatal Treatment

Fingerprint

Dive into the research topics of 'Antenatal diagnosis and treatment of congenital adrenal hyperplasia'. Together they form a unique fingerprint.

Cite this